Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma-Reference-Cited by-同舟云学术

Comparison of first-line chemotherapy including escalated BEACOPP versus chemotherapy including ABVD for people with early unfavourable or advanced stage Hodgkin lymphoma

Published:2017-05-25 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Skoetz Nicole¹,Will Andrea¹,Monsef Ina¹,Brillant Corinne¹,Engert Andreas²,von Tresckow Bastian²

Affiliation:

1. University Hospital of Cologne; Cochrane Haematological Malignancies Group, Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50937

2. University Hospital of Cologne; Department I of Internal Medicine; Kerpener Str. 62 Cologne Germany 50924

Publisher

Wiley

Subject

Pharmacology (medical)

Reference131 articles.

1. Eight cycles of ABVD versus four cycles of BEACOPP escalated plus four cycles of BEACOPP baseline in Stage III to IV, International Prognostic Score ≥ 3, high-risk Hodgkin lymphoma: First results of the Phase III EORTC 20012 Intergroup Trial;Carde;Journal of Clinical Oncology,June 2016

2. Carde PP Karrasch M Fortpied C Brice P Khaled HM Caillot D ABVD (8 cycles) versus BEACOPP (4 escalated cycles => 4 baseline) in stage III-IV high-risk Hodgkin lymphoma (HL): First results of EORTC 20012 Intergroup randomized phase III clinical trial Journal of Clinical Oncology, 30, (suppl; Abstract 8002) 2012

3. Carde PP Linch DC Divine M Sureda A Meyer RM Ma D Comparison of two combination chemotherapy regimens in treating patients with stage III or stage IV Hodgkin's Lymphoma, (NCT00049595) http://clinicaltrials.gov/ct2/show/NCT00049595 2010

4. Mounier N Brice P Bologna S Briere J Gaillard I Heczko M ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial Annals of Oncology May 2014 1622 8

5. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials;Behringer;Journal of Clinical Oncology,2013

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real‐life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experience;Hematological Oncology;2024-04-25

2. Reduced Corticosteroid Exposure Is Safe and Does Not Reduce Disease Control among Hodgkin Lymphoma Patients Treated with Escalated BEACOPP (eBEACOPP);Medicina;2024-03-02

3. How I Follow Hodgkin Lymphoma in First Complete (Metabolic) Remission?;Medicina;2024-02-19

4. Classic Hodgkin Lymphoma in Adolescents and Young Adults;Journal of Clinical Oncology;2023-11-20

5. Physician frontline treatment preferences for stage III/IV classic Hodgkin lymphoma: the real-world US CONNECT study;Future Oncology;2023-09-04